Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamoru Harada

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
Cancer Immunology, Immunotherapy : CII|May 17, 2012
Combining a peptide vaccine with oral ingestion of Lentinula edodes mycelia extract enhances anti-tumor activity in B16 melanoma-bearing miceKousuke Tanaka, Satoru Ishikawa, Yasunori Matsui, et al.
Plos One|March 8, 2018
Chloroquine augments TRAIL-induced apoptosis and induces G2/M phase arrest in human pancreatic cancer cellsHiroyuki Monma, Yuichi Iida, Tamami Moritani, et al.
International Immunopharmacology|December 3, 2022
A modulatory effect of L-arginine supplementation on anticancer effects of chemoimmunotherapy in colon cancer-bearing aged miceKazunari Ishitobi, Hitoshi Kotani, Yuichi Iida, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
In vivo evidence that peptide vaccination can induce HLA-DR-restricted CD4+ T cells reactive to a class I tumor peptideMamoru Harada, Rumi Gohara, Satoko Matsueda, et al.
BJU International|February 1, 2005
Anti-tumour activity of heat-shock protein 60-recognizing CD4+ T cells against syngeneic murine renal cell carcinomaMasatoshi Eto, Mamoru Harada, Katsunori Tatsugami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype allelesSatoko Matsueda, Hiroko Takedatsu, Akihisa Yao, et al.
Cell Proliferation|September 2, 2022
Protective roles of cytoplasmic p21<sup>Cip1</sup> <sup>/Waf1</sup> in senolysis and ferroptosis of lung cancer cellsAkira Koyanagi, Hitoshi Kotani, Yuichi Iida, et al.
Oncology Reports|November 6, 2007
HLA-G as a target molecule in specific immunotherapy against renal cell carcinomaYoshihiro Komohara, Mamoru Harada, Yuki Ishihara, et al.
Oncology Reports|October 5, 2007
New peptides of the polycomb group protein enhancer of zeste homolog 2 with the potential to induce cancer-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+ prostate cancer patientsYukoh Itoh, Yoshihiro Komohara, Nobukazu Komatsu, et al.
Cancer Science|February 27, 2024
Hypoxia-related carbonic anhydrase 9 induces serpinB9 expression in cancer cells and apoptosis in T cells via acidosisMamoru Harada, Hitoshi Kotani, Yuichi Iida, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Cancer Immunology, Immunotherapy : CII|May 17, 2012
Combining a peptide vaccine with oral ingestion of Lentinula edodes mycelia extract enhances anti-tumor activity in B16 melanoma-bearing miceKousuke Tanaka, Satoru Ishikawa, Yasunori Matsui, et al.
Plos One|March 8, 2018
Chloroquine augments TRAIL-induced apoptosis and induces G2/M phase arrest in human pancreatic cancer cellsHiroyuki Monma, Yuichi Iida, Tamami Moritani, et al.
International Immunopharmacology|December 3, 2022
A modulatory effect of L-arginine supplementation on anticancer effects of chemoimmunotherapy in colon cancer-bearing aged miceKazunari Ishitobi, Hitoshi Kotani, Yuichi Iida, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
In vivo evidence that peptide vaccination can induce HLA-DR-restricted CD4+ T cells reactive to a class I tumor peptideMamoru Harada, Rumi Gohara, Satoko Matsueda, et al.
BJU International|February 1, 2005
Anti-tumour activity of heat-shock protein 60-recognizing CD4+ T cells against syngeneic murine renal cell carcinomaMasatoshi Eto, Mamoru Harada, Katsunori Tatsugami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype allelesSatoko Matsueda, Hiroko Takedatsu, Akihisa Yao, et al.
Cell Proliferation|September 2, 2022
Protective roles of cytoplasmic p21<sup>Cip1</sup> <sup>/Waf1</sup> in senolysis and ferroptosis of lung cancer cellsAkira Koyanagi, Hitoshi Kotani, Yuichi Iida, et al.
Oncology Reports|November 6, 2007
HLA-G as a target molecule in specific immunotherapy against renal cell carcinomaYoshihiro Komohara, Mamoru Harada, Yuki Ishihara, et al.
Oncology Reports|October 5, 2007
New peptides of the polycomb group protein enhancer of zeste homolog 2 with the potential to induce cancer-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+ prostate cancer patientsYukoh Itoh, Yoshihiro Komohara, Nobukazu Komatsu, et al.
Cancer Science|February 27, 2024
Hypoxia-related carbonic anhydrase 9 induces serpinB9 expression in cancer cells and apoptosis in T cells via acidosisMamoru Harada, Hitoshi Kotani, Yuichi Iida, et al.
Pageof 11